Senior Consultant, Department of Surgical Gastroenterology, Dharamshila Narayana Superspeciality Hospital, New Delhi
Consultant, Department of GI Surgery, Indraprastha Apollo, New Delhi
Senior Consultant, GI and HPB Oncosurgery, National Cancer Institute, Nagpur
Special Senior Resident, Colorectal Service, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai
Lecturer in GI and HPB Surgical Oncology, Department of Surgical Oncology, Tata Memorial Hospital, Mumbai
HBNI Fellow GI and HPB Oncology in Department of Surgical Oncology, Tata Memorial Hospital, Mumbai
D.N.B Senior Resident in the Department of Surgical Gastroenterology and Liver Transplantation, at Sir Ganga Ram Hospital, New Delhi
Assistant Professor in the Department of General Surgery at Lady Hardinge Medical College, New Delhi
Senior Resident in the Department of General Surgery at Lady Hardinge Medical College, New Delhi
Junior Resident in the Department of General Surgery, Lady Hardinge Medical College, New Delhi
Internship at Lok Nayak Hospital attached to University College of Medical Sciences, New Delhi
M.B.B.S., MAMC & Lok Nayak Hospital, University of Delhi
M.S. (General Surgery), LHMC and SSK Hospital, University of Delhi
DNB (Surgical Gastroenterology), Sir Ganga Ram Hospital, Diplomate National Board
HBNI Fellowship GI and HPB Oncology, Tata Memorial Hospital, Mumbai, Homi Bhabha National Institute
Association of Surgeons of India (ASI)
Indian Medical Association (IMA), Gurgaon
Indian Medical Association (IMA), South Delhi
Gurgaon Oncology Forum
Open and Advanced Laparoscopic Surgeries for Cancers of Esophagus, Stomach, Liver, Gallbladder, Bile duct, Pancreas, Colon, and Rectum, etc.
Complex surgeries for liver, pancreatic, retroperitoneal tumors including cytoreductive surgery and HIPEC for peritoneal surface malignancies
Multidisciplinary and evidence-based management of gastrointestinal and HPB cancers
Training of young surgeons and Research
Scholar Badge awards for the years of 1991-92, 1992-93, 1994-95 in DPS, R.K. Puram, New Delhi.
Junior science talent search award for years 1992-94.
National talent search examination award for the year 1994.
Sanskrit Pratibha Puraskar 1994.
Awarded the travel grant by ICMR to attend ILTS 2012.
Awarded the Bursary to attend IASG 2012.
Awarded the 2nd prize for the poster presented at IASG 2012.
Awarded the prize for best poster at Indian chapter IHPBA 2014.
Mitra A, Yadav A, Mehta N, Varma V, Kumaran V, Nundy S. Complicated perianal sepsis. Indian J Surgery. Indian J Surg. 2015 Dec;77(Suppl 3):769-73.
Sirohi B, Barreto SG, Singh A, Batra S, Mitra A, Rastogi S, Ramadwar M, Shetty N, Goel M, Shrikhande SV. Epirubicin, oxaliplatin, and capecitabine is just as “MAGIC” al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer. J Cancer Res Ther. 2014 Oct-Dec;10(4):866-70.
Sirohi B, Mitra A, Jagannath P, Singh A, Ramadvar M, Kulkarni S, Goel M, Shrikhande SV. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015 May;11(10):1501-9.
Mitra A, De’souza A, Goel M, Shrikhande SV. Surgery for pancreatic and periampullary carcinoma. Indian Journal of Surgery. 2015 Oct;77(5):371-80.
Mitra A, Shrikhande SV, Sirohi B. Histopathological regression after taxane based neoadjuvant chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma. Transl Gastroenterol Hepatol. 2017 May 16;2:46.
van Rijssen LB, Gerritsen A, Henselmans I, Sprangers MA, Jacobs M, Bassi C, Busch OR, Fernández-Del Castillo C, Fong ZV, He J, Jang JY, Javed AA, Kim SW, Maggino L, Mitra A, Ostwal V, Pellegrini S, Shrikhande SV, Wilmink JW, Wolfgang CL, van Laarhoven HW, Besselink MG; COPRAC study group. Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers. Ann Surg. 2017 Dec 19. doi: 10.1097/SLA.0000000000002633.
Mitra A, Pai E, Dusane R, Ranganathan P, DeSouza A, Goel M, Shrikhande SV. Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors. Langenbecks Arch Surg. 2018 Mar;403(2):203-212. doi: 10.1007/s00423-018-1653-6.
Agarwal V, Thomas MJ, Joshi R, Chaudhari V, Bhandare M, Mitra A, deSouza A, Ambulkar R, Shrikhande SV. Improved Outcomes in 394 Pancreatic Cancer Resections: the Impact of Enhanced Recovery Pathway. J Gastrointest Surg. 2018 Oct;22(10):1732-1742. doi: 10.1007/s11605-018-3809-7.
Shinde R, Bhamre R, Niyogi D, Mitra A, Desouza A, Ostwal V, Engineer R, Dusane R, Saklani A. Does histology dictate outcomes of locally advanced rectal adenocarcinoma with complete pathological response following neoadjuvant chemoradiation? J Radiat Oncol (2018) 7: 85. https://doi.org/10.1007/s13566-017-0341-4.
Bhambre R, Mitra A, Tamankar A, Desouza A, Saklani A. Impact of Length of Distal Margin on Outcomes Following Sphincter Preserving Surgery for Middle and Lower Third Rectal Cancers. Accepted in Indian Journal of Surgical Oncology.
Mitra A, Mehta N, Varma V, Kumaran V, Nundy S. Current management of colorectal liver metastases: A perspective. The Ganga Ram Journal 2011;1:247–253.
Mitra A, Sirohi B, Shrikhande SV. Neoadjuvant therapy in pancreatic cancer. Current Medicine Research and Practice (2014), http://dx.doi.org/10.1016/j.cmrp.2014.03.002.
Mitra A, Shrikhande SV. Commentary on Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Annals of surgical oncology 2013. Pancreatic cancer India website.
Shrikhande SV, Batra S, Mitra A, Patkar S, Goel M. Neuroendocrine Tumors of Pancreas. G.I. Surgery Annual. Volume 21.2014.
Mitra A, Sirohi B, Goel M, Shrikhande SV. Borderline resectable pancreatic cancer. Evidence-Based Practices in Gastrointestinal, Colorectal and Hepatobiliary Surgery. Jaypee publishers, 2017. doi: 10.5005/jp/books/13024
Sinu kumar S, Mitra A, Shrikhande SV. Puzzling cases- 2 pancreatic cases.
Sirohi B, Mitra A, Shrikhande SV. Impact of chemoradiotherapy on postoperative complications in GI surgery.
Shrikhande SV, Mitra A. Borderline resectable pancreatic cancer- What can we expect in the next 10 years. Pancreatology the next decade. November 21, 2014
PLUS FIFTEEN ABSTRACTS IN INDEXED JOURNALS
Randomised trial: Phase III Randomised controlled trial comparing D2 versus D3 lymphadenectomy on outcomes of non-metastatic, resectable, but locally advanced, gastric cancer following neoadjuvant (perioperative) chemotherapy (ELANCe trial)”
Multicentre study: Developing a COre-set of Patient-Reported outcomes in pAncreatic Cancer (COPRAC): an international Delphi survey
Basic research study: Role of surgery-induced hypoxia in resectable periampullary and pancreatic adenocarcinoma undergoing pancreaticoduodenectomy and its correlation with changes in cell biology.
Prospective and retrospective study: Borderline resectable pancreatic tumors: outcomes of a multimodality approach
About Paras Hospitals
We have super speciality hospitals in Gurugram, Patna, Darbhanga, Panchkula, Ranchi, and Udaipur. Our initiatives are based on our three tenets of healthcare: Affordability, Accessibility, and Quality. Paras Healthcare was established in 2006, with the mission of providing specialized tertiary medical care services at affordable prices to under served communities across the country. This private healthcare provider stands apart from others in it’s vision of making healthcare for all a reality for ordinary people in rural and remote regions. Every single individual working in a ‘Paras’ Hospital- from doctors to nurses and the management- is united in the endeavor to deliver top quality healthcare to all. Paras Healthcare is a leader in establishing specialized hospitals in places that lack access to healthcare, specifically super specialty tertiary care. Each of it’s initiative is based on three tenets of healthcare- Affordability, Accessibility & Quality.